See every side of every news story
Published loading...Updated

Avecho clocks $4.7M payment from pharma giant Sandoz for CBD capsule licence

Summary by themarketonline.com.au
Avecho (ASX:AVE) has received a US$3 million (A$4.7 million) payment from pharma heavyweight Sandoz in exchange for the latter’s right to use Avecho’s licence for a CBD capsule sleeping pill. Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more. The term ‘CBD’ refers to the non-psychoactive element within marijuana (the bit that gets you high is c…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

themarketonline.com.au broke the news in on Friday, March 28, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.